A suspicious AAA-themed email uses car safety fears to push drivers toward a questionable link. The sender address, shared URL and missing official branding are major warning signs. The email cites a ...

Most people treat Excel as a rigid calculator, completely missing its capacity for chaos. Excel's built-in randomization tools can generate numbers, shuffle existing lists, and build mock timelines in ...

Encryption systems rely on “random” numbers, but conventional computers can’t generate them perfectly. New research shows that quantum physics can. By Alexander Nazaryan Researchers in Switzerland ...

We received an email that looks like an official HR notice about a performance review. It mentions pay updates, benefits and a deadline. There is also a QR code to access your file. The message claims ...

Email spam used to be one of the major annoyances of the digital world. But in recent years, email providers have taken steps to improve our overflowing inboxes, which were often riddled with ...

Simple Builders is a Java annotation processor designed to generate type-safe and high-performance builders for Java classes. It generates builder code at compile-time, ensuring type safety without ...

Email signature generator EmailSignatures lets you create polished, professional email signatures in minutes. More than simply bolding your name, you can add your company’s logo, your social links — ...

Almost everything you do online asks for your email. If you have been using the same one for a while, chances are hundreds or even thousands of services have it. They send promotional messages, social ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

If a hacker or scammer has access to your email, every account connected to it is at risk. We show you how to protect yourself fast. I review privacy tools like hardware security keys, password ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...